Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer
Cancer Genomics - Proteomics · 2024
DOI: 10.21873/cgp.20450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2024. Verfasst von Keiko Sato und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Information Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan; keiko@is.noda.tus.ac.jp. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Information Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan; keiko@is.noda.tus.ac.jp.
- Department of Information Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.
- Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
Zitieren
APA
Sato, K., Miura, K., Tamori, S., & Akimoto, K. (2024). Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20450
Vancouver
Sato K, Miura K, Tamori S, Akimoto K. Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer. Cancer Genomics - Proteomics. 2024. doi:10.21873/cgp.20450
BibTeX
@article{Sato2024,
author = {Sato, Keiko and Miura, Kentaro and Tamori, Shoma and Akimoto, Kazunori},
title = {Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer},
journal = {Cancer Genomics - Proteomics},
year = {2024},
doi = {10.21873/cgp.20450}
}
EUVIMED